Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 90
Filter
1.
Ned Tijdschr Geneeskd ; 1642020 08 25.
Article in Dutch | MEDLINE | ID: mdl-32940977

ABSTRACT

At the so-called in-bore, MRI-guided prostate biopsy, the radiologist in the MRI suite manually directs a rectal biopsy needle guide at an abnormality confirmed by a previous prostate MRI. This manual technique of taking a biopsy is time-consuming and thus rather expensive, as the patient has to be moved in and out of the MRI several times. Since 2015, a remote-controlled manipulator robot (RCM) has been available. Using this apparatus the radiologist is able to position the needle guide remotely. This technique is simple to learn and less time-consuming than the in-bore biopsy without the RCM. In this article we discuss the findings from the first 201 patients in the Netherlands from whom robot-guided prostate biopsies have been taken.


Subject(s)
Biopsy, Needle/methods , Image-Guided Biopsy/methods , Magnetic Resonance Imaging , Prostatic Neoplasms/diagnosis , Robotics/methods , Humans , Male , Netherlands , Rectum
2.
Insights Imaging ; 6(6): 611-30, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26385690

ABSTRACT

OBJECTIVES: The purpose of this pictorial review is to present a wide spectrum of prostate multiparametric MRI (mp-MRI) pitfalls that may occur in clinical practice, with radiological and pathological correlation. METHODS: All examinations were performed according to ESUR Guidelines protocols. RESULTS AND CONCLUSION: mp-MRI imaging of the prostate often leads to interpreting doubts and misdiagnosis due to the many interpretative pitfalls that a tissue, whether healthy or treated, may cause. These "false-positive" findings may occur in each stage of the disease history, from the primary diagnosis and staging, to the post-treatment stage, and whether they are caused by the tissue itself or are iatrogenic, their recognition is critical for proper treatment and management. Knowledge of these known pitfalls and their interpretation in the anatomical-radiological context can help radiologists avoid misdiagnosis and consequently mistreatment. MAIN MESSAGES: • Some physiological changes in the peripheral and central zone may simulate prostate cancer. • Technical errors, such as mispositioned endorectal coils, can affect the mp-MRI interpretation. • Physiological changes post-treatment can simulate recurrence.

3.
Eur Radiol ; 24(8): 1950-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24865699

ABSTRACT

OBJECTIVES: To assess the image quality of T2-weighted (T2w) magnetic resonance imaging of the prostate and the visibility of prostate cancer at 7 Tesla (T). MATERIALS & METHODS: Seventeen prostate cancer patients underwent T2w imaging at 7T with only an external transmit/receive array coil. Three radiologists independently scored images for image quality, visibility of anatomical structures, and presence of artefacts. Krippendorff's alpha and weighted kappa statistics were used to assess inter-observer agreement. Visibility of prostate cancer lesions was assessed by directly linking the T2w images to the confirmed location of prostate cancer on histopathology. RESULTS: T2w imaging at 7T was achievable with 'satisfactory' (3/5) to 'good' (4/5) quality. Visibility of anatomical structures was predominantly scored as 'satisfactory' (3/5) and 'good' (4/5). If artefacts were present, they were mostly motion artefacts and, to a lesser extent, aliasing artefacts and noise. Krippendorff's analysis revealed an α = 0.44 between three readers for the overall image quality scores. Clinically significant cancer lesions in both peripheral zone and transition zone were visible at 7T. CONCLUSION: T2w imaging with satisfactory to good quality can be routinely acquired, and cancer lesions were visible in patients with prostate cancer at 7T using only an external transmit/receive body array coil. KEY POINTS: • Satisfactory to good T2-weighted image quality of the prostate is achievable at 7T. • Periprostatic lipids appear hypo-intense compared to healthy peripheral zone tissue at 7T. • Prostate cancer is visible on T2-weighted MRI at 7T.


Subject(s)
Artifacts , Image Enhancement , Magnetic Resonance Imaging/methods , Neoplasm Staging/methods , Prostate/pathology , Prostatic Neoplasms/diagnosis , Aged , Humans , Male , Middle Aged , Reproducibility of Results
4.
J Urol ; 190(5): 1728-34, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23680307

ABSTRACT

PURPOSE: We determined the positive and negative predictive values of multiparametric magnetic resonance imaging for extraprostatic extension at radical prostatectomy for different prostate cancer risk groups. MATERIALS AND METHODS: We evaluated a cohort of 183 patients who underwent 3 Tesla multiparametric magnetic resonance imaging, including T2-weighted, diffusion weighted magnetic resonance imaging and dynamic contrast enhanced sequences, with an endorectal coil before radical prostatectomy. Pathological stage at radical prostatectomy was used as standard reference for extraprostatic extension. The cohort was classified into low, intermediate and high risk groups according to the D'Amico criteria. We recorded prevalence of extraprostatic extension at radical prostatectomy and determined sensitivity, specificity, positive predictive value and negative predictive value of multiparametric magnetic resonance imaging for extraprostatic extension in each group. Univariate and multivariate analyses were performed to identify predictors of extraprostatic extension at radical prostatectomy. RESULTS: The overall prevalence of extraprostatic extension at radical prostatectomy was 49.7% ranging from 24.7% to 77.1% between low and high risk categories. Overall staging accuracy of multiparametric magnetic resonance imaging for extraprostatic extension was 73.8%, with sensitivity, specificity, positive predictive value and negative predictive value of 58.2%, 89.1%, 84.1% and 68.3%, respectively. Positive predictive value of multiparametric magnetic resonance imaging for extraprostatic extension was best in the high risk cohort with 88.8%. Negative predictive value was highest in the low risk cohort with 87.7%. With an odds ratio of 10.3 multiparametric magnetic resonance imaging is by far the best preoperative predictor of extraprostatic extension at radical prostatectomy. CONCLUSIONS: For adequate patient counseling, knowledge of predictive values of multiparametric magnetic resonance imaging for extraprostatic extension is of utmost importance. High negative predictive value, important for decisions on nerve sparing strategies at radical prostatectomy, is only reached in low risk subjects.


Subject(s)
Magnetic Resonance Imaging/methods , Prostatic Neoplasms/pathology , Humans , Male , Middle Aged , Neoplasm Invasiveness , Predictive Value of Tests , Prostatectomy , Prostatic Neoplasms/surgery , Rectum , Risk Assessment
5.
Eur Radiol ; 22(7): 1451-64, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22562143

ABSTRACT

Many therapeutic approaches to cancer affect the tumour vasculature, either indirectly or as a direct target. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has become an important means of investigating this action, both pre-clinically and in early stage clinical trials. For such trials, it is essential that the measurement process (i.e. image acquisition and analysis) can be performed effectively and with consistency among contributing centres. As the technique continues to develop in order to provide potential improvements in sensitivity and physiological relevance, there is considerable scope for between-centre variation in techniques. A workshop was convened by the Imaging Committee of the Experimental Cancer Medicine Centres (ECMC) to review the current status of DCE-MRI and to provide recommendations on how the technique can best be used for early stage trials. This review and the consequent recommendations are summarised here. Key Points • Tumour vascular function is key to tumour development and treatment • Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assess tumour vascular function • Thus DCE-MRI with pharmacokinetic models can assess novel treatments • Many recent developments are advancing the accuracy of and information from DCE-MRI • Establishing common methodology across multiple centres is challenging and requires accepted guidelines.


Subject(s)
Clinical Trials as Topic/standards , Contrast Media/standards , Magnetic Resonance Imaging/standards , Neoplasms/pathology , Neovascularization, Pathologic/pathology , Practice Guidelines as Topic , Europe , Humans , Neoplasms/blood supply , Reference Standards
6.
Phys Med Biol ; 57(6): 1527-42, 2012 Mar 21.
Article in English | MEDLINE | ID: mdl-22391091

ABSTRACT

In this paper, a fully automatic computer-aided detection (CAD) method is proposed for the detection of prostate cancer. The CAD method consists of multiple sequential steps in order to detect locations that are suspicious for prostate cancer. In the initial stage, a voxel classification is performed using a Hessian-based blob detection algorithm at multiple scales on an apparent diffusion coefficient map. Next, a parametric multi-object segmentation method is applied and the resulting segmentation is used as a mask to restrict the candidate detection to the prostate. The remaining candidates are characterized by performing histogram analysis on multiparametric MR images. The resulting feature set is summarized into a malignancy likelihood by a supervised classifier in a two-stage classification approach. The detection performance for prostate cancer was tested on a screening population of 200 consecutive patients and evaluated using the free response operating characteristic methodology. The results show that the CAD method obtained sensitivities of 0.41, 0.65 and 0.74 at false positive (FP) levels of 1, 3 and 5 per patient, respectively. In conclusion, this study showed that it is feasible to automatically detect prostate cancer at a FP rate lower than systematic biopsy. The CAD method may assist the radiologist to detect prostate cancer locations and could potentially guide biopsy towards the most aggressive part of the tumour.


Subject(s)
Diagnosis, Computer-Assisted/statistics & numerical data , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/statistics & numerical data , Prostatic Neoplasms/diagnosis , Adenocarcinoma/diagnosis , Aged , Algorithms , Automation , Biopsy , Cohort Studies , Databases, Factual , Humans , Male , Middle Aged , ROC Curve
7.
Med Phys ; 38(11): 6178-87, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22047383

ABSTRACT

PURPOSE: Computer aided diagnosis (CAD) of lymph node metastases may help reduce reading time and improve interpretation of the large amount of image data in a 3-D pelvic MRI exam. The purpose of this study was to develop an algorithm for automated segmentation of pelvic lymph nodes from a single seed point, as part of a CAD system for the classification of normal vs metastatic lymph nodes, and to evaluate its performance compared to other algorithms. METHODS: The authors' database consisted of pelvic MR images of 146 consecutive patients, acquired between January 2008 and April 2010. Each dataset included four different MR sequences, acquired after infusion of a lymph node specific contrast medium based on ultrasmall superparamagnetic particles of iron oxide. All data sets were analyzed by two expert readers who, reading in consensus, annotated and manually segmented the lymph nodes. The authors compared four segmentation algorithms: confidence connected region growing (CCRG), extended CCRG (ECC), graph cut segmentation (GCS), and a segmentation method based on a parametric shape and appearance model (PSAM). The methods were ranked based on spatial overlap with the manual segmentations, and based on diagnostic accuracy in a CAD system, with the experts' annotations as reference standard. RESULTS: A total of 2347 manually annotated lymph nodes were included in the analysis, of which 566 contained a metastasis. The mean spatial overlap (Dice similarity coefficient) was: 0.35 (CCRG), 0.57 (ECC), 0.44 (GCS), and 0.46 (PSAM). When combined with the classification system, the area under the ROC curve was: 0.805 (CCRG), 0.890 (ECC), 0.807 (GCS), 0.891 (PSAM), and 0.935 (manual segmentation). CONCLUSIONS: We identified two segmentation methods, ECC and PSAM, that achieve a high diagnostic accuracy when used in conjunction with a CAD system for classification of normal vs metastatic lymph nodes. The manual segmentations still achieve the highest diagnostic accuracy.


Subject(s)
Imaging, Three-Dimensional/methods , Lymph Nodes , Magnetic Resonance Imaging/methods , Pelvis , Automation , Lymphatic Metastasis
8.
Oral Oncol ; 47(11): 1079-84, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21856211

ABSTRACT

Pilot study evaluating the diagnostic value of magnetic resonance lymphography (MRL) compared with conventional imaging techniques in the preoperative staging of the clinically (palpable) negative neck (cN0) in squamous cell carcinoma of the oral cavity (SCCOC). Patients with SCCOC without clinical evidence of lymph node metastasis and scheduled for surgery underwent MRL in combination with ultrasound with or without fine needle aspiration cytology and multi-detector computer tomography. MRL images were interpreted by 2 independent radiologists. All patients were planned for resection of the primary tumor and a selective neck dissection of levels I-III. Histopathologic results were evaluated as the gold standard and compared with preoperative findings. One of nine evaluated patients had a metastatic node on histopathologic analysis. In all but 1 patient, MRL showed possible metastatic spread in at least 1 node. On a node-to-node basis, negative predictive value (NPV) and sensitivity reached 100% for 1.5- en 3Tesla (T) MRL, specificity reached 92% at 1.5T and 93% at 3T MRL, and positive predictive value (PPV) was 8% at 1.5T MRL, for both radiologists. PPV at 3T MRL was 10% and 9%, for radiologists I and II, respectively. This pilot study shows that MRL has a high NPV based on a node-to-node analysis. However, its PPV was only 10%, and therefore its use as a single imaging technique in the preoperative staging of the cN0 neck in SCCOC seems to be limited. Further studies are needed to confirm these data.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Mouth Neoplasms/diagnosis , Female , Humans , Lymph Node Excision , Lymphatic Metastasis/diagnosis , Lymphography/methods , Magnetic Resonance Spectroscopy/methods , Male , Neck/surgery , Pilot Projects , Prospective Studies , Sensitivity and Specificity
9.
J Endourol ; 24(5): 775-80, 2010 May.
Article in English | MEDLINE | ID: mdl-20477543

ABSTRACT

PURPOSE: To establish a consensus in relation to case selection, conduct of therapy, and outcomes that are associated with focal therapy for men with localized prostate cancer. MATERIAL AND METHODS: Urologic surgeons, radiation oncologists, radiologists, and histopathologists from North America and Europe participated in a consensus workshop on focal therapy for prostate cancer. The consensus process was face to face within a structured meeting, in which pertinent clinical issues were raised, discussed, and agreement sought. Where no agreement was possible, this was acknowledged, and the nature of the disagreement noted. RESULTS: Candidates for focal treatment should have unilateral low- to intermediate-risk disease with clinical stage

Subject(s)
Prostate/surgery , Prostatic Neoplasms/therapy , Europe , Humans , Male , North America , Patient Selection , Prostate/pathology , Prostatic Neoplasms/pathology
10.
Breast Cancer Res Treat ; 119(2): 415-22, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19885731

ABSTRACT

Re-excision rates after breast conserving surgery(BCS) of invasive lobular carcinoma (ILC) are high.Preoperative breast MRI has the potential to reduce re-excision rates, but may lead to an increased rate of mastectomies. Hence, we assessed the influence of preoperative breast MRI on the re-excision rate and the rate of mastectomies. We performed a retrospective cohort study of a consecutive series of patients with ILC who presented in one of two dedicated tertiary cancer centers between 1993 and 2005. We assessed the initial type of surgery(BCS or mastectomy), the re-excision rate and the final type of surgery. Patients were stratified into two groups:those who received preoperative MRI (MR? group) and those who did not (MR- group). In the MR- group, 27%of the patients underwent a re-excision after initial BCS. In the MR? group, this rate was significantly lower at 9%.The odds ratio was 3.64 (95% CI: 1.30-10.20, P = 0.010).There was a trend towards a lower final mastectomy rate in the MR? group compared to the MR- group (48 vs. 59%,P = 0.098). In conclusion, preoperative MRI in patients with ILC can reduce re-excision rates without increasing the rate of mastectomies.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma, Lobular/pathology , Carcinoma, Lobular/surgery , Magnetic Resonance Imaging , Mastectomy, Segmental , Mastectomy , Adult , Aged , Aged, 80 and over , Female , Humans , Middle Aged , Neoplasm Invasiveness , Netherlands , Odds Ratio , Predictive Value of Tests , Preoperative Care , Reoperation , Retrospective Studies , Risk Assessment , Time Factors , Treatment Outcome
11.
Eur Radiol ; 19(7): 1565-74, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19194709

ABSTRACT

The purpose of this study was to define guidelines for endometrial cancer staging with MRI. The technique included critical review and expert consensus of MRI protocols by the female imaging subcommittee of the European Society of Urogenital Radiology, from ten European institutions, and published literature between 1999 and 2008. The results indicated that high field MRI should include at least two T2-weighted sequences in sagittal, axial oblique or coronal oblique orientation (short and long axis of the uterine body) of the pelvic content. High-resolution post-contrast images acquired at 2 min +/- 30 s after intravenous contrast injection are suggested to be optimal for the diagnosis of myometrial invasion. If cervical invasion is suspected, additional slice orientation perpendicular to the axis of the endocervical channel is recommended. Due to the limited sensitivity of MRI to detect lymph node metastasis without lymph node-specific contrast agents, retroperitoneal lymph node screening with pre-contrast sequences up to the level of the kidneys is optional. The likelihood of lymph node invasion and the need for staging lymphadenectomy are also indicated by high-grade histology at endometrial tissue sampling and by deep myometrial or cervical invasion detected by MRI. In conclusion, expert consensus and literature review lead to an optimized MRI protocol to stage endometrial cancer.


Subject(s)
Endometrial Neoplasms/pathology , Magnetic Resonance Imaging/standards , Neoplasm Staging/standards , Practice Guidelines as Topic , Europe , Female , Humans
12.
Cancer Treat Rev ; 35(4): 309-21, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19136215

ABSTRACT

The development of targeted therapies is a major breakthrough in the treatment of cancer. By evoking necrosis and cavitation, evaluation based on tumour size alone, as is done in the RECIST criteria, is no longer an adequate method. New molecular and functional imaging techniques are developed. This review focuses on the use of new imaging modalities for the evaluation of treatment response of pathway based targeted therapies. First, the basic principles of functional and molecular imaging modalities are briefly discussed. Thereafter, their clinical application in targeted therapies is correlated to the underlying biological mechanism. In this way, the best method for response evaluation for a new agent can be identified.


Subject(s)
Diagnostic Imaging/methods , Drug Delivery Systems , Image Enhancement/methods , Neoplasms/diagnosis , Neoplasms/drug therapy , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Clinical Trials as Topic , Female , Fluorodeoxyglucose F18 , Humans , Magnetic Resonance Imaging/methods , Male , Molecular Biology , Positron-Emission Tomography/methods , Sensitivity and Specificity , Tomography, X-Ray Computed
13.
Clin Radiol ; 63(4): 387-95, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18325358

ABSTRACT

AIM: To compare the diagnostic accuracy of computed tomography (CT) and magnetic resonance imaging (MRI) in the diagnosis of lymph node metastases in prostate cancer. METHODS: After a comprehensive literature search, studies were included that allowed construction of contingency tables for detection of lymph node metastases using CT or MRI. In addition, a summary receiver-operating characteristic (ROC) analysis was performed. RESULTS: A total of 24 studies were included. For CT, pooled sensitivity was 0.42 (0.26-0.56 95% CI) and pooled specificity was 0.82 (0.8-0.83 95% CI). For MRI, the pooled sensitivity was 0.39 (0.22-0.56 95% CI) and pooled specificity was 0.82 (0.79-0.83 95% CI). The differences in performance of CT and MRI were not statistically significant. CONCLUSION: CT and MRI demonstrate an equally poor performance in the detection of lymph node metastases from prostate cancer. Reliance on either CT or MRI will misrepresent the patient's true status regarding nodal metastases, and thus misdirect the therapeutic strategies offered to the patient.


Subject(s)
Magnetic Resonance Imaging/standards , Pelvic Neoplasms/diagnosis , Prostatic Neoplasms/pathology , Tomography, X-Ray Computed/standards , Humans , Lymph Nodes , Lymphatic Metastasis , Male , Neoplasm Staging , Pelvic Neoplasms/pathology , Pelvic Neoplasms/secondary , ROC Curve , Sensitivity and Specificity
14.
Eur Radiol ; 18(6): 1123-33, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18270714

ABSTRACT

The value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in characterizing breast lesions on magnetic resonance imaging (MRI) was evaluated. Sixty-eight malignant and 34 benign lesions were included. In the scanning protocol, high temporal resolution imaging was combined with high spatial resolution imaging. The high temporal resolution images were recorded every 4.1 s during initial enhancement (fast dynamic analysis). The high spatial resolution images were recorded at a temporal resolution of 86 s (slow dynamic analysis). In the fast dynamic evaluation pharmacokinetic parameters (K(trans), V(e) and k(ep)) were evaluated. In the slow dynamic analysis, each lesion was scored according to the BI-RADS classification. Two readers evaluated all data prospectively. ROC and multivariate analysis were performed. The slow dynamic analysis resulted in an AUC of 0.85 and 0.83, respectively. The fast dynamic analysis resulted in an AUC of 0.83 in both readers. The combination of both the slow and fast dynamic analyses resulted in a significant improvement of diagnostic performance with an AUC of 0.93 and 0.90 (P = 0.02). The increased diagnostic performance found when combining both methods demonstrates the additional value of our method in further improving the diagnostic performance of breast MRI.


Subject(s)
Breast Neoplasms/pathology , Contrast Media/pharmacokinetics , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Meglumine/pharmacokinetics , Organometallic Compounds/pharmacokinetics , Adult , Aged , Area Under Curve , Diagnosis, Differential , Female , Humans , Image Enhancement/methods , Middle Aged , Prospective Studies , ROC Curve
15.
Acta Radiol ; 49(1): 107-20, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18210320

ABSTRACT

As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. Magnetic resonance imaging (MRI) may enhance the staging of prostate cancer compared with clinical evaluation, transrectal ultrasound, or computed tomography (CT), and allows concurrent evaluation of prostatic, periprostatic, and pelvic anatomy. In clinical practice, the fusion of MRI or dynamic contrast-enhanced MRI (DCE-MRI) with MR spectroscopic imaging (MRSI) is improving the evaluation of cancer location, size, and extent, while providing an indication of tumor aggressiveness. Pretreatment knowledge of these prognostic variables is essential for achieving minimally invasive, patient-specific therapy.


Subject(s)
Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy/methods , Positron-Emission Tomography/methods , Prostatic Neoplasms/diagnosis , Tomography, X-Ray Computed/methods , Diffusion Magnetic Resonance Imaging/methods , Humans , Magnetic Resonance Imaging/trends , Male , Neoplasm Staging , Prostate/diagnostic imaging , Prostate/pathology
16.
Eur J Surg Oncol ; 34(2): 135-42, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17574805

ABSTRACT

AIMS: Invasive lobular carcinoma of the breast (ILC) is known to be substantially underestimated by mammography, which makes correct planning of treatment difficult. MRI has been proposed as a valuable adjunct to mammography. The purpose of the current study is to evaluate its value, compare it to mammography and assess the possible causes of over- and underestimation of lesion size on MRI. METHOD: The mammograms and MRI scans of 67 consecutive patients with ILC were retrieved and re-evaluated. Size measurements were correlated to the sizes extracted from the pathology report. RESULTS: MRI measurements correlated better to pathologic size (r=0.85) than mammographic measurements (r=0.27). Underestimation of tumour size was more common on mammography (p<0.001); overestimation occurred with equal frequency (p=0.69). Overestimation on MRI, caused by non-malignant findings, was attributed to enhancing lobular carcinoma in situ. CONCLUSION: MRI is a more accurate modality for determining tumour size in patients with ILC than mammography. The typical underestimation of lesion size by mammography can be prevented with the aid of MRI, without increasing the risk of lesion overestimation.


Subject(s)
Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Carcinoma, Lobular/diagnostic imaging , Carcinoma, Lobular/pathology , Magnetic Resonance Imaging/methods , Mammography/methods , Adult , Aged , Biopsy, Needle , Evaluation Studies as Topic , Female , Follow-Up Studies , Humans , Immunohistochemistry , Middle Aged , Neoplasm Invasiveness/pathology , Neoplasm Staging , Probability , Registries , Retrospective Studies , Sensitivity and Specificity
17.
NMR Biomed ; 20(2): 128-40, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17006886

ABSTRACT

Systemic chemotherapy is effective in only a subset of patients with metastasized colorectal cancer. Therefore, early selection of patients who are most likely to benefit from chemotherapy is desirable. Response to treatment may be determined by the delivery of the drug to the tumor, retention of the drug in the tumor and by the amount of intracellular uptake, metabolic activation and catabolism, as well as other factors. The first aim of this study was to investigate the predictive value of DCE-MRI with the contrast agent Gd-DTPA for tumor response to first-line chemotherapy in patients with liver metastases of colorectal cancer. The second aim was to investigate the predictive value of 5-fluorouracil (FU) uptake, retention and catabolism as measured by localized (19)F MRS for tumor response to FU therapy. Since FU uptake, retention and metabolism may depend on tumor vascularization, the relationship between (19)F MRS and the DCE-MRI parameters k(ep), K(trans) and v(e) was also examined (1). In this study, 37 patients were included. The kinetic parameters of DCE-MRI, k(ep), K(trans) and v(e), before start of treatment did not predict tumor response after 2 months, suggesting that the delivery of chemotherapy by tumor vasculature is not a major factor determining response in first-line treatment. No evident correlations between (19)F MRS parameters and tumor response were found. This suggests that in liver metastases that are not selected on the basis of their tumor diameter, FU uptake and catabolism are not limiting factors for response. The transfer constant K(trans), as measured by DCE-MRI before start of treatment, was negatively correlated with FU half-life in the liver metastases, which suggests that, in metastases with a larger tumor blood flow or permeability surface area product, FU is rapidly washed out from the tumor.


Subject(s)
Colorectal Neoplasms/drug therapy , Fluorouracil/pharmacokinetics , Gadolinium DTPA , Liver Neoplasms/secondary , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy/methods , Adult , Aged , Colorectal Neoplasms/pathology , Contrast Media , Female , Fluorouracil/therapeutic use , Humans , Image Enhancement , Male , Middle Aged
18.
Clin Imaging ; 30(2): 94-8, 2006.
Article in English | MEDLINE | ID: mdl-16500539

ABSTRACT

The aim of the study was to evaluate mammography in detecting and staging of invasive lobular carcinoma (ILC) in order to assess the performance and impact of observer variability. Forty-two cases of ILC were retrospectively evaluated twice by two breast radiologists. Mammographic performance as well as intra- and interobserver variations was evaluated. Thirty-five percent to 37% of the cases were understaged. The largest differences between radiologists were found in the breast imaging reporting and data system (BIRADS) classification and staging performance. These results can have serious influence on patient management.


Subject(s)
Breast Neoplasms/diagnostic imaging , Carcinoma, Lobular/diagnostic imaging , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma, Lobular/pathology , Carcinoma, Lobular/surgery , Humans , Mammography , Middle Aged , Neoplasm Staging , Observer Variation , Retrospective Studies
19.
Eur Urol ; 49(4): 698-703, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16464531

ABSTRACT

OBJECTIVES: To determine whether the failure of chemotherapy in patients with regionally metastatic or unresectable transitional cell carcinoma (TCC) of the bladder can be predicted early in the course of chemotherapy with magnetic resonance (MR) imaging. METHODS: In this prospective study, 36 patients with regionally metastatic or unresectable TCC of the urinary bladder underwent MR imaging before and after two, four, and six cycles of chemotherapy with Methotrexate, Vinblastine, Adriamycin (doxorubicin) and Cisplatin (MVAC). The response after two cycles of MVAC was evaluated by using conventional tumour size parameters with unenhanced MR imaging and with changes in the time to the start of tumour or lymph node enhanced at fast dynamic contrast-enhanced MR imaging. The results obtained with these techniques were compared with the findings at histopathology in cystectomy or transurethral resection specimens that were obtained after chemotherapy. Duration of survival was defined as the time from the start of chemotherapy until disease-specific death. Kaplan-Meier curves were drawn to determine the difference in prognosis between responders and nonresponders. RESULTS: After two cycles of chemotherapy, the accuracy, sensitivity, and specificity in distinguishing responders from nonresponders with conventional MR imaging were 69%, 81%, and 50%, respectively. With the fast dynamic contrast-enhanced technique, accuracy, sensitivity, and specificity were 92%, 91%, and 93% respectively. The median bladder cancer specific survival was 28 months for all patients studied. Responders to chemotherapy at fast dynamic contrast-enhanced MR had better median disease-specific survival than nonresponders (42 months vs. 12 months [p<0.0001]). CONCLUSION: We can predict whether a patient will respond to chemotherapy after two cycles of chemotherapy with fast dynamic contrast-enhanced MR imaging.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Transitional Cell/drug therapy , Carcinoma, Transitional Cell/pathology , Magnetic Resonance Imaging/methods , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/pathology , Adult , Aged , Cisplatin/administration & dosage , Contrast Media , Doxorubicin/administration & dosage , Female , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Survival Analysis , Treatment Outcome , Vinblastine/administration & dosage
20.
Urol Int ; 71(4): 430-2, 2003.
Article in English | MEDLINE | ID: mdl-14646447

ABSTRACT

A 67-year-old man was treated with maintenance intravesical BCG for superficial bladder cancer. As a culture-proven complication of this therapy, he developed general malaise, high fever, granulomatous hepatitis and a mycotic aneurysm in his left knee. All complications were treated successfully with antituberculous therapy. No vascular surgery was necessary. This case report again stresses the necessity to recognise complications of BCG treatment and to start adequate therapy as soon as possible.


Subject(s)
Adjuvants, Immunologic/adverse effects , Aneurysm, Infected/etiology , BCG Vaccine/adverse effects , Carcinoma, Transitional Cell/drug therapy , Popliteal Artery , Tuberculosis, Cardiovascular/etiology , Urinary Bladder Neoplasms/drug therapy , Administration, Intravesical , Aged , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...